CAS 1619923-36-2

Pelcitoclax

CAS: 1619923-36-2

Pelcitoclax is an anticancer drug that targets kinases involved in cancer cell survival and apoptosis. It works by inhibiting the activity of specific proteins that are essential for the growth and survival of cancer cells. Pelcitoclax has been shown to be effective against a variety of human cancer cell lines, including Chinese hamster ovary cells and tumor cells from patients with various types of cancer. This drug is a potent inhibitor of mirtazapine, which is an analog of Pelcitoclax found in urine. Pelcitoclax has been studied extensively as a potential therapeutic agent for the treatment of various cancers, and its kinase inhibition properties make it a promising candidate for future cancer therapies.

Fórmula: C₅₇H₆₆ClF₄N₆O₁₁PS₄

Pureza: Min. 95%

Peso molecular: 1,281.9 g/mol

Ref: 3D-UPC92336

Pelcitoclax

CAS: 1619923-36-2

Pelcitoclax (APG-1252) is a powerful inhibitor of the Bcl-2 and Bcl-xl proteins, displaying significant antineoplastic and pro-apoptotic properties[1].

Fórmula: C₅₇H₆₆ClF₄N₆O₁₁PS₄

Cor e Forma: Solid

Peso molecular: 1281.84

Ref: TM-T36901